<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
	<front>
		<journal-meta>
    <journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
    <journal-id journal-id-type="publisher-id">plos</journal-id>
    <journal-id journal-id-type="pmc">plosone</journal-id>
    <journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group>
    <issn pub-type="epub">1932-6203</issn>
    <publisher><publisher-name>Public Library of Science</publisher-name>
    <publisher-loc>San Francisco, USA</publisher-loc></publisher>
    </journal-meta><article-meta>
			<article-id pub-id-type="publisher-id">PONE-D-13-23135</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0076915</article-id><article-categories><subj-group subj-group-type="heading">
    <subject>Research Article</subject></subj-group></article-categories><title-group>
				<article-title>The -607C/A Polymorphisms in Interleukin-18 Gene Promoter Contributes to Cancer Risk: Evidence from A Meta-Analysis of 22 Case-Control Studies</article-title>
			<alt-title alt-title-type="running-head">IL-18 -607C/A Polymorphism and Cancer Risk</alt-title>
      </title-group>
			<contrib-group>
				<contrib xlink:type="simple" contrib-type="author">
					<name name-style="western">
						<surname>Wang</surname>
						<given-names>Ming</given-names>
					</name>
					<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
					<xref ref-type="corresp" rid="cor1"><sup>*</sup></xref>
				</contrib>
				<contrib xlink:type="simple" contrib-type="author">
					<name name-style="western">
						<surname>Zhu</surname>
						<given-names>Xiao-Yang</given-names>
					</name>
					<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
				</contrib>
				<contrib xlink:type="simple" contrib-type="author">
					<name name-style="western">
						<surname>Wang</surname>
						<given-names>Liang</given-names>
					</name>
					<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
				</contrib>
				<contrib xlink:type="simple" contrib-type="author">
					<name name-style="western">
						<surname>Lin</surname>
						<given-names>Yu</given-names>
					</name>
					<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
				</contrib>
			</contrib-group>
			<aff id="aff1"><label>1</label> <addr-line>Department of Radiation Therapy, Cangzhou Central Hospital, Cangzhou, Hebei Province, China</addr-line></aff>
			<aff id="aff2"><label>2</label> <addr-line>Department of Radiation Therapy, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China</addr-line></aff>
			<aff id="aff3"><label>3</label> <addr-line>Department of Endoscopic Professional, Cangzhou Central Hospital, Cangzhou, Hebei Province, China</addr-line></aff>
			<aff id="aff4"><label>4</label> <addr-line>Department of Radiation Therapy, the Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Neimenggu Province, China</addr-line></aff>
			<contrib-group><contrib contrib-type="editor" xlink:type="simple">
          <name name-style="western">
            <surname>Wei</surname>
            <given-names>Qing-Yi</given-names>
          </name>
          <role>Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
        </contrib-group><aff id="edit1"><addr-line>Duke Cancer Institute, United States of America</addr-line></aff><author-notes>
				<corresp id="cor1">*E-mail: <email xlink:type="simple">mwangm@yeah.net</email></corresp>
			<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con"><p>Conceived and designed the experiments: MW XYZ LW YL. Performed the experiments: MW XYZ LW YL. Analyzed the data: MW ZXY. Contributed reagents/materials/analysis tools: MW XYZ LW YL. Wrote the manuscript: MW XYZ LW YL. </p></fn></author-notes>
			<pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub">
        <day>9</day>
        <month>10</month>
        <year>2013</year>
      </pub-date>
      <volume>8</volume><issue>10</issue><elocation-id>e76915</elocation-id><history><date date-type="received">
          <day>4</day>
          <month>6</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>8</month>
          <year>2013</year>
        </date>
      </history><permissions>
    <copyright-year>2013</copyright-year><copyright-holder>Wang et al</copyright-holder><license xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license>
    </permissions><abstract>
				<sec sec-type="headed">
					<title>Background</title><p>Several observational studies have investigated the association between -607 C/A polymorphism of IL-18 gene and cancer risk; however, the results were inconsistent. Therefore, we performed a meta-analysis to derive a more precise estimation of the association to help us better understand the relationship between -607 C/A polymorphism of IL-18 gene promoter and risk of cancer.</p>
				</sec>
				<sec sec-type="headed">
					<title>Methods</title><p>A literature search was carried out using PubMed, EMBASE, and China National Knowledge Infrastructure (CNKI) database between January 1966 and February 2013. Fixed-effect and random-effect models were used to estimate the pooled odds ratio (OR) and the corresponding 95% confidence intervals (CIs).</p>
				</sec>
				<sec sec-type="headed">
					<title>Results</title><p>A total of 22 case-control studies including 4100 cancer cases and 4327 controls contributed to the analysis. Significant association between <named-content content-type="gene" xlink:type="simple">-607C/A</named-content> polymorphism in IL-18 gene promoter and cancer risk was observed (CA vs CC:OR =1.221, 95% CI: 1.096, 1.360; P<sub>heterogeneity</sub>=0.219; <named-content content-type="gene" xlink:type="simple">AA/CA</named-content> vs. CC:OR =1.203, 95% CI: 1.057, 1.369; P<sub>heterogeneity</sub>=0.064). In the subgroup analysis by ethnicity, <named-content content-type="gene" xlink:type="simple">-607C/A</named-content> polymorphism significantly increased risk of cancer among Asian population (<named-content content-type="gene" xlink:type="simple">AA/CA</named-content> vs. CC:OR =1.197, 95% CI: 1.023,1.401; P<sub>heterogeneity</sub>=0.088); however, no significant association was found in Caucasian or African population. The <named-content content-type="gene" xlink:type="simple">-607C/A</named-content> polymorphism was associated with a significantly increased risk of nasopharyngeal carcinoma (CA vs CC:OR =1.330, 95% CI: 1.029,1.719; P<sub>heterogeneity</sub>=0.704; <named-content content-type="gene" xlink:type="simple">AA/CA</named-content> vs. CC:OR =1.323, 95% CI: 1.037,1.687; P<sub>heterogeneity</sub>=0.823) and esophageal cancer (<named-content content-type="gene" xlink:type="simple">AA/CA</named-content> vs. CC:OR =1.289, 95% CI: 1.002,1.658; P<sub>heterogeneity</sub>=0.700).</p>
				</sec>
				<sec sec-type="headed">
					<title>Conclusions</title><p>The present meta-analysis suggests that the <named-content content-type="gene" xlink:type="simple">-607C/A</named-content> polymorphisms in IL-18 gene promoter is associated with a significantly increased risk of cancer, especially for nasopharyngeal carcinoma and esophageal cancer and in Asian population. More studies with larger sample size, well controlled confounding factors are warranted to validate this association.</p>
				</sec>
			</abstract>
		<funding-group><funding-statement>The authors have no support or funding to report.</funding-statement></funding-group></article-meta>
	</front>
	<body>
		<sec id="s1" sec-type="introduction">
			<title>Introduction</title>
			<p>IL-1 family includes ten known members, all of which are characterized by gene structure, predicted three-dimensional fold, processing, receptor, signal transduction pathway and pro-inflammatory properties [<xref ref-type="bibr" rid="B1">1</xref>]. IL-18, also known as interferon-gamma inducing factor (IGIF), is a member of the IL-1 super-family [<xref ref-type="bibr" rid="B2">2</xref>]. IL-18 is secreted by a wide range of cells, including T and B lymphocytes, and antigen-presenting cells (APCs), including activated monocytes, macrophages, Kupffer cells, Langerhans cells, and NK cells [<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B5">5</xref>]. IL-1 beta converting enzyme can convert IL-18 to a mature biologically active 18.3-kDa form through cleavage of the propeptide. IL-18 binds to the cell through a specific receptor, IL-18R, belonging to the toll-like receptor family [<xref ref-type="bibr" rid="B6">6</xref>]. IL-18 plays a central role in inflammation and immune response, and is generally acknowledged as a key defense cytokine against infectious agents. Because immune stimulating effects of IL-18 have also antineoplastic properties, it was tempting to propose IL-18 as a novel adjuvant therapy against cancer [<xref ref-type="bibr" rid="B7">7</xref>]. A number of single nucleotide polymorphisms (SNPs) of IL-18 gene have been identified and investigated [<xref ref-type="bibr" rid="B8">8</xref>]. There are three SNPs in the promoter region of IL-18 gene: -137, -607 and -656, relative to the transcriptional start site, which may alter the expression of IL-18 [<xref ref-type="bibr" rid="B9">9</xref>]. The C to A substitution at position −607 disrupts a consensus cAMP-responsive element protein-binding site, causing altered transcription factor binding and gene expression [<xref ref-type="bibr" rid="B9">9</xref>]. Several observational studies have investigated the association between -607 C/A polymorphism of IL-18 gene promoter and cancer risk; however, the results were inconsistent. For example, some studies found that -607 C/A polymorphism of IL-18 gene promoter was associated with increased risk of nasopharyngeal carcinoma [<xref ref-type="bibr" rid="B10">10</xref>] and lung cancer [<xref ref-type="bibr" rid="B11">11</xref>]. However, other studies found there was no association between -607 C/A polymorphism of IL-18 gene and risk of breast cancer [<xref ref-type="bibr" rid="B12">12</xref>] or head and neck squamous cell carcinoma [<xref ref-type="bibr" rid="B13">13</xref>]. Therefore, we performed a meta-analysis to derive a more precise estimation of the association to help us better understand the relationship between -607 C/A polymorphism of IL-18 gene and risk of cancer.</p>
		</sec>
		<sec id="s2" sec-type="methods">
			<title>Methods</title>
			<sec id="s2.1">
				<title>Identification of studies</title>
				<p>Comprehensive searches were carried out using PubMed, EMBASE, and China National Knowledge Infrastructure (CNKI) databases between January 1966 and February 2013. There were no restriction of origin and languages. Search terms included: "Interleukin-18" or "IL-18" or "rs1946518" in combination with “polymorphism” or “variant” and ‘‘cancer’’ or ‘‘neoplasm’’ or ‘‘malignancy’’. The reference list of each comparative study and previous reviews were manually examined to ﬁnd additional relevant studies.</p>
			</sec>
			<sec id="s2.2">
				<title>Inclusion and exclusion criteria</title>
				<p>Studies were selected according to the following inclusion criteria: (i) case-control studies; (ii) investigating the association between IL-18 rs1946518 (C&gt;A) SNP and cancer risk; (iii)cancers diagnosed by histopathology; (iiii) providing detail genotype frequencies. Studies without detail genotype frequencies were excluded. Titles and abstracts of searching results were screened and full text papers were further evaluated to confirm eligibility. Two reviewers (WM and ZXY) independently selected eligible trials. Disagreement between the two reviewers was settled by discussing with the third reviewer(WL).</p>
			</sec>
			<sec id="s2.3">
				<title>Data extraction</title>
				<p>In the present study, the following characteristics were collected by two reviewers (WM and LY) independently using a purpose-designed form: name of first author, publishing time, country where the study was conducted, ethnicity, cancer types, source of control, number of cases and controls, genotype frequency in cases and controls. Different ethnicity descents were categorized as Asian, Caucasian, and African. Cancer types were classified as prostate cancer, esophageal cancer, nasopharyngeal carcinoma, colorectal cancer, breast cancer, cervical cancer, and other cancers (bladder cancer, renal cell carcinoma, head and neck squamous cell carcinoma, lung cancer, stomach cancer, ovarian cancer, choriocarcinoma, and oral cancer). Eligible studies were defined as hospital-based (HB) and population-based (PB) according to the control source.</p>
			</sec>
			<sec id="s2.4">
				<title>Statistical analysis</title>
				<p>Chi-square based Q test was used to check the statistical heterogeneity between studies, and the heterogeneity was considered significant when p&lt;0.10 [<xref ref-type="bibr" rid="B14">14</xref>]. The fixed-effects model (based on Mantel-Haenszel method) and random-effects model (based on DerSimonian-Laird method) were used to pool the data from different studies. The fixed-effects model was used when there was no significant heterogeneity; otherwise, the random-effects model was applied [<xref ref-type="bibr" rid="B15">15</xref>]. The association strength between -607 C/A (rs1946518) polymorphism and cancer risk was measured by odds ratio (OR) with 95% confidence intervals (95% CI). The estimates of pooled ORs were achieved by calculating a weighted average of OR from each study. A 95% CI was used for statistical significance test and a 95% CI without 1 for OR indicating a significant increased or reduced cancer risk. The pooled ORs were calculated for homozygote comparison (AA versus CC), heterozygote comparison (CA versus CC), dominant (<named-content content-type="gene" xlink:type="simple">CA/AA</named-content> versus CC) and recessive (AA versus <named-content content-type="gene" xlink:type="simple">CC/CA</named-content>) modes, assuming dominant and recessive effects of the variant A allele, respectively. Subgroup analyses were performed according to (i) cancer types, (ii) ethnicities, (iii) source of control, and (iiii) sample size, to examine the impact of these factors on the association. To test the robustness of association, sensitivity analysis were carried out by excluding studies one-by-one and analyzing the effect size for all of rest studies. Cumulative meta-analysis was also performed to identify the change in trend of reporting risk over time. In cumulative meta-analysis, studies were chronologically ordered by publication year, then the pooled RRs were obtained at the end of each year. To better investigate the possible sources of between-study heterogeneity, a meta-regression analysis was performed [<xref ref-type="bibr" rid="B16">16</xref>]. Publication bias was assessed using Begg and Mazumdar adjusted rank correlation test and the Egger regression asymmetry test [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B18">18</xref>]. HWE(Hardy-Weinberg equilibrium) was tested by Pearson’s X<sup>2</sup> test (P&lt;0.05 means deviated from HWE). All analyses were performed using Stata version 11.0 (StataCorp, College Station, TX).</p>
			</sec>
		</sec>
		<sec id="s3" sec-type="results">
			<title>Results</title>
			<sec id="s3.1">
				<title>Search results and characteristics of studies included in the meta-analysis</title>
				<p>A total of 792 citations were identified during the initial search (shown in <xref ref-type="fig" rid="pone-0076915-g001">Figure 1</xref>). On the basis of the title and abstract, we identified 24 papers. After detailed evaluation, one study was excluded for incorrect data, and two studies were excluded for having not presented -607 C/A polymorphisms. In the study reported by Haghshenas MR and colleagues [<xref ref-type="bibr" rid="B19">19</xref>], they investigated rs1946518 polymorphisms and colorectal cancer, as well as stomach cancer, and the data was presented separately, thus both of them were considered as a separate study in this meta-analysis. At last, 22 case-control studies [<xref ref-type="bibr" rid="B10">10</xref>-<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B19">19</xref>-<xref ref-type="bibr" rid="B35">35</xref>], including 4100 cancer cases and 4327 controls, were included in the meta-analysis(Baseline data and other details are shown in <xref ref-type="table" rid="pone-0076915-t001">Table 1</xref>). 16 eligible studies were conducted in Asia [<xref ref-type="bibr" rid="B11">11</xref>-<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B23">23</xref>-<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B35">35</xref>], five in Europe [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B33">33</xref>], and the remaining one in Africa [<xref ref-type="bibr" rid="B22">22</xref>]. There were five studies including more than 500 participants and the others had a sample size less than 500 participants. Genotype distribution of controls in all studies was consistent with HWE.</p>
				<fig id="pone-0076915-g001" position="float">
					<object-id pub-id-type="doi">10.1371/journal.pone.0076915.g001</object-id><label>Figure 1</label>
					<caption>
						<title>Flow diagram of the study selection process.</title>
					</caption>
					<graphic xlink:type="simple" position="float" xlink:href="info:doi/10.1371/journal.pone.0076915.g001"/>
				</fig>
				<table-wrap id="pone-0076915-t001" position="float">
					<object-id pub-id-type="doi">10.1371/journal.pone.0076915.t001</object-id><label>Table 1</label>
					<caption>
						<title>Characteristics of studies included in the meta-analysis.</title>
					</caption>
					<table>
						<colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup>
						<thead>
							<tr>
								<th rowspan="1" colspan="1">First Author</th>
								<th rowspan="1" colspan="1">Year</th>
								<th rowspan="1" colspan="1">Country</th>
								<th rowspan="1" colspan="1">Ethnicity</th>
								<th rowspan="1" colspan="1">Control</th>
								<th rowspan="1" colspan="1">No. of Cases</th>
								<th rowspan="1" colspan="1">No. of Controls</th>
								<th rowspan="1" colspan="1">Cancer Type</th>
								<th rowspan="1" colspan="1">Sample size</th>
								<th rowspan="1" colspan="1">Cases</th>
								<th rowspan="1" colspan="1"/>
								<th rowspan="1" colspan="1"/>
								<th rowspan="1" colspan="1">Controls</th>
								<th rowspan="1" colspan="1"/>
								<th rowspan="1" colspan="1"/>
							</tr>
						</thead>
						<tbody>
							<tr>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1">AA</td>
								<td rowspan="1" colspan="1">CA</td>
								<td rowspan="1" colspan="1">CC</td>
								<td rowspan="1" colspan="1">AA</td>
								<td rowspan="1" colspan="1">CA</td>
								<td rowspan="1" colspan="1">CC</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Liu JM</td>
								<td rowspan="1" colspan="1">2013</td>
								<td rowspan="1" colspan="1">China</td>
								<td rowspan="1" colspan="1">Asian</td>
								<td rowspan="1" colspan="1">Population Based</td>
								<td rowspan="1" colspan="1">375</td>
								<td rowspan="1" colspan="1">400</td>
								<td rowspan="1" colspan="1">Prostate Cancer</td>
								<td rowspan="1" colspan="1">Large</td>
								<td rowspan="1" colspan="1">103</td>
								<td rowspan="1" colspan="1">172</td>
								<td rowspan="1" colspan="1">100</td>
								<td rowspan="1" colspan="1">110</td>
								<td rowspan="1" colspan="1">196</td>
								<td rowspan="1" colspan="1">94</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Babar M</td>
								<td rowspan="1" colspan="1">2012</td>
								<td rowspan="1" colspan="1">UK</td>
								<td rowspan="1" colspan="1">Caucasian</td>
								<td rowspan="1" colspan="1">Population Based</td>
								<td rowspan="1" colspan="1">1070</td>
								<td rowspan="1" colspan="1">194</td>
								<td rowspan="1" colspan="1">Esophageal Cancer</td>
								<td rowspan="1" colspan="1">Large</td>
								<td rowspan="1" colspan="1">178</td>
								<td rowspan="1" colspan="1">508</td>
								<td rowspan="1" colspan="1">384</td>
								<td rowspan="1" colspan="1">36</td>
								<td rowspan="1" colspan="1">75</td>
								<td rowspan="1" colspan="1">83</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Du B</td>
								<td rowspan="1" colspan="1">2012</td>
								<td rowspan="1" colspan="1">China</td>
								<td rowspan="1" colspan="1">Asian</td>
								<td rowspan="1" colspan="1">Hospital Based</td>
								<td rowspan="1" colspan="1">150</td>
								<td rowspan="1" colspan="1">180</td>
								<td rowspan="1" colspan="1">Nasopharyngeal Carcinoma</td>
								<td rowspan="1" colspan="1">Small</td>
								<td rowspan="1" colspan="1">34</td>
								<td rowspan="1" colspan="1">80</td>
								<td rowspan="1" colspan="1">36</td>
								<td rowspan="1" colspan="1">40</td>
								<td rowspan="1" colspan="1">93</td>
								<td rowspan="1" colspan="1">47</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Guo JY</td>
								<td rowspan="1" colspan="1">2012</td>
								<td rowspan="1" colspan="1">China</td>
								<td rowspan="1" colspan="1">Asian</td>
								<td rowspan="1" colspan="1">Hospital Based</td>
								<td rowspan="1" colspan="1">170</td>
								<td rowspan="1" colspan="1">160</td>
								<td rowspan="1" colspan="1">Colorectal Cancer</td>
								<td rowspan="1" colspan="1">Small</td>
								<td rowspan="1" colspan="1">49</td>
								<td rowspan="1" colspan="1">85</td>
								<td rowspan="1" colspan="1">36</td>
								<td rowspan="1" colspan="1">42</td>
								<td rowspan="1" colspan="1">76</td>
								<td rowspan="1" colspan="1">42</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Taheri M</td>
								<td rowspan="1" colspan="1">2012</td>
								<td rowspan="1" colspan="1">Iran</td>
								<td rowspan="1" colspan="1">Asian</td>
								<td rowspan="1" colspan="1">Population Based</td>
								<td rowspan="1" colspan="1">72</td>
								<td rowspan="1" colspan="1">93</td>
								<td rowspan="1" colspan="1">Breast Cancer</td>
								<td rowspan="1" colspan="1">Small</td>
								<td rowspan="1" colspan="1">11</td>
								<td rowspan="1" colspan="1">32</td>
								<td rowspan="1" colspan="1">29</td>
								<td rowspan="1" colspan="1">8</td>
								<td rowspan="1" colspan="1">45</td>
								<td rowspan="1" colspan="1">40</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Saenz-Lopez P</td>
								<td rowspan="1" colspan="1">2010</td>
								<td rowspan="1" colspan="1">Spain</td>
								<td rowspan="1" colspan="1">Caucasian</td>
								<td rowspan="1" colspan="1">Population Based</td>
								<td rowspan="1" colspan="1">154</td>
								<td rowspan="1" colspan="1">500</td>
								<td rowspan="1" colspan="1">Other Types</td>
								<td rowspan="1" colspan="1">Large</td>
								<td rowspan="1" colspan="1">19</td>
								<td rowspan="1" colspan="1">76</td>
								<td rowspan="1" colspan="1">59</td>
								<td rowspan="1" colspan="1">73</td>
								<td rowspan="1" colspan="1">261</td>
								<td rowspan="1" colspan="1">166</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Asefi V</td>
								<td rowspan="1" colspan="1">2009</td>
								<td rowspan="1" colspan="1">Iran</td>
								<td rowspan="1" colspan="1">Asian</td>
								<td rowspan="1" colspan="1">Hospital Based</td>
								<td rowspan="1" colspan="1">111</td>
								<td rowspan="1" colspan="1">212</td>
								<td rowspan="1" colspan="1">Other Types</td>
								<td rowspan="1" colspan="1">Small</td>
								<td rowspan="1" colspan="1">15</td>
								<td rowspan="1" colspan="1">53</td>
								<td rowspan="1" colspan="1">43</td>
								<td rowspan="1" colspan="1">29</td>
								<td rowspan="1" colspan="1">101</td>
								<td rowspan="1" colspan="1">82</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Farjadfar A</td>
								<td rowspan="1" colspan="1">2009</td>
								<td rowspan="1" colspan="1">Iran</td>
								<td rowspan="1" colspan="1">Asian</td>
								<td rowspan="1" colspan="1">Hospital Based</td>
								<td rowspan="1" colspan="1">73</td>
								<td rowspan="1" colspan="1">97</td>
								<td rowspan="1" colspan="1">Other Types</td>
								<td rowspan="1" colspan="1">Small</td>
								<td rowspan="1" colspan="1">13</td>
								<td rowspan="1" colspan="1">45</td>
								<td rowspan="1" colspan="1">15</td>
								<td rowspan="1" colspan="1">11</td>
								<td rowspan="1" colspan="1">46</td>
								<td rowspan="1" colspan="1">40</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Haghshenas MR</td>
								<td rowspan="1" colspan="1">2009</td>
								<td rowspan="1" colspan="1">Iran</td>
								<td rowspan="1" colspan="1">Asian</td>
								<td rowspan="1" colspan="1">Population Based</td>
								<td rowspan="1" colspan="1">142</td>
								<td rowspan="1" colspan="1">311</td>
								<td rowspan="1" colspan="1">Colorectal Cancer</td>
								<td rowspan="1" colspan="1">Small</td>
								<td rowspan="1" colspan="1">15</td>
								<td rowspan="1" colspan="1">72</td>
								<td rowspan="1" colspan="1">55</td>
								<td rowspan="1" colspan="1">48</td>
								<td rowspan="1" colspan="1">144</td>
								<td rowspan="1" colspan="1">119</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Haghshenas MR</td>
								<td rowspan="1" colspan="1">2009</td>
								<td rowspan="1" colspan="1">Iran</td>
								<td rowspan="1" colspan="1">Asian</td>
								<td rowspan="1" colspan="1">Population Based</td>
								<td rowspan="1" colspan="1">87</td>
								<td rowspan="1" colspan="1">311</td>
								<td rowspan="1" colspan="1">Other Types</td>
								<td rowspan="1" colspan="1">Small</td>
								<td rowspan="1" colspan="1">16</td>
								<td rowspan="1" colspan="1">40</td>
								<td rowspan="1" colspan="1">31</td>
								<td rowspan="1" colspan="1">48</td>
								<td rowspan="1" colspan="1">144</td>
								<td rowspan="1" colspan="1">119</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Khalili-Azad T</td>
								<td rowspan="1" colspan="1">2009</td>
								<td rowspan="1" colspan="1">Iran</td>
								<td rowspan="1" colspan="1">Asian</td>
								<td rowspan="1" colspan="1">Population Based</td>
								<td rowspan="1" colspan="1">200</td>
								<td rowspan="1" colspan="1">206</td>
								<td rowspan="1" colspan="1">Breast Cancer</td>
								<td rowspan="1" colspan="1">Small</td>
								<td rowspan="1" colspan="1">33</td>
								<td rowspan="1" colspan="1">103</td>
								<td rowspan="1" colspan="1">64</td>
								<td rowspan="1" colspan="1">33</td>
								<td rowspan="1" colspan="1">97</td>
								<td rowspan="1" colspan="1">76</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Nong LG</td>
								<td rowspan="1" colspan="1">2009</td>
								<td rowspan="1" colspan="1">China</td>
								<td rowspan="1" colspan="1">Asian</td>
								<td rowspan="1" colspan="1">Population Based</td>
								<td rowspan="1" colspan="1">250</td>
								<td rowspan="1" colspan="1">270</td>
								<td rowspan="1" colspan="1">Nasopharyngeal Carcinoma</td>
								<td rowspan="1" colspan="1">Large</td>
								<td rowspan="1" colspan="1">71</td>
								<td rowspan="1" colspan="1">132</td>
								<td rowspan="1" colspan="1">47</td>
								<td rowspan="1" colspan="1">68</td>
								<td rowspan="1" colspan="1">133</td>
								<td rowspan="1" colspan="1">69</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Samsami DA</td>
								<td rowspan="1" colspan="1">2009</td>
								<td rowspan="1" colspan="1">Iran</td>
								<td rowspan="1" colspan="1">Asian</td>
								<td rowspan="1" colspan="1">Hospital Based</td>
								<td rowspan="1" colspan="1">85</td>
								<td rowspan="1" colspan="1">158</td>
								<td rowspan="1" colspan="1">Other Types</td>
								<td rowspan="1" colspan="1">Small</td>
								<td rowspan="1" colspan="1">12</td>
								<td rowspan="1" colspan="1">51</td>
								<td rowspan="1" colspan="1">22</td>
								<td rowspan="1" colspan="1">26</td>
								<td rowspan="1" colspan="1">75</td>
								<td rowspan="1" colspan="1">57</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Farhat K</td>
								<td rowspan="1" colspan="1">2008</td>
								<td rowspan="1" colspan="1">Tunisia</td>
								<td rowspan="1" colspan="1">African</td>
								<td rowspan="1" colspan="1">Population Based</td>
								<td rowspan="1" colspan="1">163</td>
								<td rowspan="1" colspan="1">164</td>
								<td rowspan="1" colspan="1">Nasopharyngeal Carcinoma</td>
								<td rowspan="1" colspan="1">Small</td>
								<td rowspan="1" colspan="1">28</td>
								<td rowspan="1" colspan="1">94</td>
								<td rowspan="1" colspan="1">41</td>
								<td rowspan="1" colspan="1">34</td>
								<td rowspan="1" colspan="1">77</td>
								<td rowspan="1" colspan="1">53</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Kashef MA</td>
								<td rowspan="1" colspan="1">2008</td>
								<td rowspan="1" colspan="1">Iran</td>
								<td rowspan="1" colspan="1">Asian</td>
								<td rowspan="1" colspan="1">Population Based</td>
								<td rowspan="1" colspan="1">19</td>
								<td rowspan="1" colspan="1">103</td>
								<td rowspan="1" colspan="1">Other Types</td>
								<td rowspan="1" colspan="1">Small</td>
								<td rowspan="1" colspan="1">3</td>
								<td rowspan="1" colspan="1">10</td>
								<td rowspan="1" colspan="1">6</td>
								<td rowspan="1" colspan="1">16</td>
								<td rowspan="1" colspan="1">54</td>
								<td rowspan="1" colspan="1">33</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Qi T</td>
								<td rowspan="1" colspan="1">2008</td>
								<td rowspan="1" colspan="1">China</td>
								<td rowspan="1" colspan="1">Asian</td>
								<td rowspan="1" colspan="1">Hospital Based</td>
								<td rowspan="1" colspan="1">50</td>
								<td rowspan="1" colspan="1">50</td>
								<td rowspan="1" colspan="1">Cervical Cancer</td>
								<td rowspan="1" colspan="1">Small</td>
								<td rowspan="1" colspan="1">28</td>
								<td rowspan="1" colspan="1">17</td>
								<td rowspan="1" colspan="1">5</td>
								<td rowspan="1" colspan="1">9</td>
								<td rowspan="1" colspan="1">24</td>
								<td rowspan="1" colspan="1">17</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Liu Y</td>
								<td rowspan="1" colspan="1">2007</td>
								<td rowspan="1" colspan="1">China</td>
								<td rowspan="1" colspan="1">Asian</td>
								<td rowspan="1" colspan="1">Hospital Based</td>
								<td rowspan="1" colspan="1">265</td>
								<td rowspan="1" colspan="1">280</td>
								<td rowspan="1" colspan="1">Prostate Cancer</td>
								<td rowspan="1" colspan="1">Large</td>
								<td rowspan="1" colspan="1">72</td>
								<td rowspan="1" colspan="1">143</td>
								<td rowspan="1" colspan="1">50</td>
								<td rowspan="1" colspan="1">78</td>
								<td rowspan="1" colspan="1">137</td>
								<td rowspan="1" colspan="1">65</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Nikiteas N</td>
								<td rowspan="1" colspan="1">2007</td>
								<td rowspan="1" colspan="1">Greece</td>
								<td rowspan="1" colspan="1">Caucasian</td>
								<td rowspan="1" colspan="1">Population Based</td>
								<td rowspan="1" colspan="1">84</td>
								<td rowspan="1" colspan="1">89</td>
								<td rowspan="1" colspan="1">Colorectal Cancer</td>
								<td rowspan="1" colspan="1">Small</td>
								<td rowspan="1" colspan="1">18</td>
								<td rowspan="1" colspan="1">47</td>
								<td rowspan="1" colspan="1">19</td>
								<td rowspan="1" colspan="1">22</td>
								<td rowspan="1" colspan="1">32</td>
								<td rowspan="1" colspan="1">35</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Vairaktaris E</td>
								<td rowspan="1" colspan="1">2007</td>
								<td rowspan="1" colspan="1">Germany</td>
								<td rowspan="1" colspan="1">Caucasian</td>
								<td rowspan="1" colspan="1">Population Based</td>
								<td rowspan="1" colspan="1">149</td>
								<td rowspan="1" colspan="1">89</td>
								<td rowspan="1" colspan="1">Other Types</td>
								<td rowspan="1" colspan="1">Small</td>
								<td rowspan="1" colspan="1">28</td>
								<td rowspan="1" colspan="1">66</td>
								<td rowspan="1" colspan="1">55</td>
								<td rowspan="1" colspan="1">22</td>
								<td rowspan="1" colspan="1">32</td>
								<td rowspan="1" colspan="1">35</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Wei YS</td>
								<td rowspan="1" colspan="1">2007</td>
								<td rowspan="1" colspan="1">China</td>
								<td rowspan="1" colspan="1">Asian</td>
								<td rowspan="1" colspan="1">Hospital Based</td>
								<td rowspan="1" colspan="1">235</td>
								<td rowspan="1" colspan="1">250</td>
								<td rowspan="1" colspan="1">Esophageal Cancer</td>
								<td rowspan="1" colspan="1">Small</td>
								<td rowspan="1" colspan="1">64</td>
								<td rowspan="1" colspan="1">123</td>
								<td rowspan="1" colspan="1">48</td>
								<td rowspan="1" colspan="1">67</td>
								<td rowspan="1" colspan="1">124</td>
								<td rowspan="1" colspan="1">59</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Yang HL</td>
								<td rowspan="1" colspan="1">2007</td>
								<td rowspan="1" colspan="1">China</td>
								<td rowspan="1" colspan="1">Asian</td>
								<td rowspan="1" colspan="1">Population Based</td>
								<td rowspan="1" colspan="1">107</td>
								<td rowspan="1" colspan="1">80</td>
								<td rowspan="1" colspan="1">Cervical Cancer</td>
								<td rowspan="1" colspan="1">Small</td>
								<td rowspan="1" colspan="1">24</td>
								<td rowspan="1" colspan="1">50</td>
								<td rowspan="1" colspan="1">33</td>
								<td rowspan="1" colspan="1">36</td>
								<td rowspan="1" colspan="1">26</td>
								<td rowspan="1" colspan="1">18</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Pratesi C</td>
								<td rowspan="1" colspan="1">2006</td>
								<td rowspan="1" colspan="1">Italy</td>
								<td rowspan="1" colspan="1">Caucasian</td>
								<td rowspan="1" colspan="1">Population Based</td>
								<td rowspan="1" colspan="1">89</td>
								<td rowspan="1" colspan="1">130</td>
								<td rowspan="1" colspan="1">Nasopharyngeal Carcinoma</td>
								<td rowspan="1" colspan="1">Small</td>
								<td rowspan="1" colspan="1">21</td>
								<td rowspan="1" colspan="1">42</td>
								<td rowspan="1" colspan="1">26</td>
								<td rowspan="1" colspan="1">23</td>
								<td rowspan="1" colspan="1">64</td>
								<td rowspan="1" colspan="1">43</td>
							</tr>
						</tbody>
					</table>
				</table-wrap>
			</sec>
			<sec id="s3.2">
				<title>Main results</title>
				<p>Given that the P value of Q-tests was less than 0.10 under the allelic, homozygous, recessive, and dominant genetic models, the random-effects model was used. By contrast, the P value of Q-tests was more than 0.10 under the heterozygous genetic model (P for heterogeneity = 0.219); thus, the fixed-effects model was adopted. Significant associations between <named-content content-type="gene" xlink:type="simple">-607C/A</named-content> polymorphisms in IL-18 gene promoter and cancer risk were observed in the heterozygous model (CA vs CC:OR =1.221, 95% CI: 1.096, 1.360; P<sub>heterogeneity</sub>=0.219, <xref ref-type="fig" rid="pone-0076915-g002">Figure 2</xref>) and the dominant model (<named-content content-type="gene" xlink:type="simple">AA/CA</named-content> vs. CC:OR =1.203, 95% CI: 1.057, 1.369; P<sub>heterogeneity</sub>=0.064, <xref ref-type="fig" rid="pone-0076915-g003">Figure 3</xref>) in this meta-analysis. However, no significant association between <named-content content-type="gene" xlink:type="simple">-607C/A</named-content> polymorphisms in IL-18 gene promoter and cancer risk was observed under the allelic model(A vs C:OR =1.088, 95% CI: 0.987,1.200; P<sub>heterogeneity</sub>=0.003), homozygous model(AA vs CC:OR =1.139, 95% CI: 0.948, 1.369; P<sub>heterogeneity</sub>=0.023), and recessive model (AA vs. <named-content content-type="gene" xlink:type="simple">CC/CA</named-content>: OR =0.995, 95% CI: 0.851, 1.163; P<sub>heterogeneity</sub>=0.025) (shown in <xref ref-type="table" rid="pone-0076915-t002">Table 2</xref>).</p>
				<fig id="pone-0076915-g002" position="float">
					<object-id pub-id-type="doi">10.1371/journal.pone.0076915.g002</object-id><label>Figure 2</label>
					<caption>
						<title>Forest plot of heterozygote comparison for overall comparison (CA vs. CC).</title>
					</caption>
					<graphic xlink:type="simple" position="float" xlink:href="info:doi/10.1371/journal.pone.0076915.g002"/>
				</fig>
				<fig id="pone-0076915-g003" position="float">
					<object-id pub-id-type="doi">10.1371/journal.pone.0076915.g003</object-id><label>Figure 3</label>
					<caption>
						<title>Forest plot of dominant model for overall comparison (<named-content content-type="gene" xlink:type="simple">CA/AA</named-content> vs. CC).</title>
					</caption>
					<graphic xlink:type="simple" position="float" xlink:href="info:doi/10.1371/journal.pone.0076915.g003"/>
				</fig>
				<table-wrap id="pone-0076915-t002" position="float">
					<object-id pub-id-type="doi">10.1371/journal.pone.0076915.t002</object-id><label>Table 2</label>
					<caption>
						<title>Stratified analyses of the <named-content content-type="gene" xlink:type="simple">-607C/A</named-content> polymorphisms in IL-18 gene promoter with cancer risk.</title>
					</caption>
					<table>
						<colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup>
						<thead>
							<tr>
								<th rowspan="1" colspan="1"/>
								<th colspan="3" rowspan="1">A vs. C<hr/></th>
								<th colspan="3" rowspan="1">AA vs. CC<hr/></th>
								<th colspan="3" rowspan="1">CA vs. CC<hr/></th>
								<th colspan="3" rowspan="1">AA vs. <named-content content-type="gene" xlink:type="simple">CC/CA</named-content><hr/></th>
								<th colspan="3" rowspan="1"><named-content content-type="gene" xlink:type="simple">AA/CA</named-content> vs. CC<hr/></th>
							</tr>
							<tr>
								<th rowspan="1" colspan="1"/>
								<th rowspan="1" colspan="1">Study  </th>
								<th rowspan="1" colspan="1">OR(95% CI)</th>
								<th rowspan="1" colspan="1">Phet</th>
								<th rowspan="1" colspan="1">Study</th>
								<th rowspan="1" colspan="1">OR(95% CI)</th>
								<th rowspan="1" colspan="1">Phet</th>
								<th rowspan="1" colspan="1">Study</th>
								<th rowspan="1" colspan="1">OR(95% CI)</th>
								<th rowspan="1" colspan="1">Phet</th>
								<th rowspan="1" colspan="1">Study</th>
								<th rowspan="1" colspan="1">OR(95% CI)</th>
								<th rowspan="1" colspan="1">Phet</th>
								<th rowspan="1" colspan="1">Study</th>
								<th rowspan="1" colspan="1">OR(95% CI)</th>
								<th rowspan="1" colspan="1">Phet</th>
							</tr>
						</thead>
						<tbody>
							<tr>
								<td rowspan="1" colspan="1">Overall</td>
								<td rowspan="1" colspan="1">23</td>
								<td rowspan="1" colspan="1">1.088 (0.987-1.200)</td>
								<td rowspan="1" colspan="1">0.003</td>
								<td rowspan="1" colspan="1">23</td>
								<td rowspan="1" colspan="1">1.139 (0.948-1.369)</td>
								<td rowspan="1" colspan="1">0.023</td>
								<td rowspan="1" colspan="1">23</td>
								<td rowspan="1" colspan="1">1.221 (1.096-1.360)*</td>
								<td rowspan="1" colspan="1">0.219</td>
								<td rowspan="1" colspan="1">23</td>
								<td rowspan="1" colspan="1">0.995 (0.851-1.163)</td>
								<td rowspan="1" colspan="1">0.025</td>
								<td rowspan="1" colspan="1">23</td>
								<td rowspan="1" colspan="1">1.203 (1.057-1.369)*</td>
								<td rowspan="1" colspan="1">0.064</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Ethnicity</td>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Asian</td>
								<td rowspan="1" colspan="1">17</td>
								<td rowspan="1" colspan="1">1.107 (0.972-1.260)</td>
								<td rowspan="1" colspan="1">0.001</td>
								<td rowspan="1" colspan="1">17</td>
								<td rowspan="1" colspan="1">1.196 (0.936-1.530)</td>
								<td rowspan="1" colspan="1">0.007</td>
								<td rowspan="1" colspan="1">17</td>
								<td rowspan="1" colspan="1">1.191 (1.047-1.356)*</td>
								<td rowspan="1" colspan="1">0.487</td>
								<td rowspan="1" colspan="1">17</td>
								<td rowspan="1" colspan="1">1.035 (0.854-1.255)</td>
								<td rowspan="1" colspan="1">0.011</td>
								<td rowspan="1" colspan="1">17</td>
								<td rowspan="1" colspan="1">1.197(1.023,1.401)*</td>
								<td rowspan="1" colspan="1">0.088</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Caucasian</td>
								<td rowspan="1" colspan="1">5</td>
								<td rowspan="1" colspan="1">1.041 (0.909-1.193)</td>
								<td rowspan="1" colspan="1">0.336</td>
								<td rowspan="1" colspan="1">5</td>
								<td rowspan="1" colspan="1">1.023 (0.779-1.343)</td>
								<td rowspan="1" colspan="1">0.473</td>
								<td rowspan="1" colspan="1">5</td>
								<td rowspan="1" colspan="1">1.294 (0.906-1.848)</td>
								<td rowspan="1" colspan="1">0.041</td>
								<td rowspan="1" colspan="1">5</td>
								<td rowspan="1" colspan="1">0.890 (0.696-1.138)</td>
								<td rowspan="1" colspan="1">0.620</td>
								<td rowspan="1" colspan="1">5</td>
								<td rowspan="1" colspan="1">1.198 (0.888-1.618)</td>
								<td rowspan="1" colspan="1">0.083</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">African</td>
								<td rowspan="1" colspan="1">1</td>
								<td rowspan="1" colspan="1">1.076 (0.790-1.464)</td>
								<td rowspan="1" colspan="1">NA</td>
								<td rowspan="1" colspan="1">1</td>
								<td rowspan="1" colspan="1">1.065 (0.558-2.030)</td>
								<td rowspan="1" colspan="1">NA</td>
								<td rowspan="1" colspan="1">1</td>
								<td rowspan="1" colspan="1">1.578 (0.951-2.620)</td>
								<td rowspan="1" colspan="1">NA</td>
								<td rowspan="1" colspan="1">1</td>
								<td rowspan="1" colspan="1">0.793 (0.455-1.382)</td>
								<td rowspan="1" colspan="1">NA</td>
								<td rowspan="1" colspan="1">1</td>
								<td rowspan="1" colspan="1">1.421 (0.877-2.301)</td>
								<td rowspan="1" colspan="1">NA</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Source of controls</td>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Hospital based</td>
								<td rowspan="1" colspan="1">9</td>
								<td rowspan="1" colspan="1">1.247 (1.022-1.523)*</td>
								<td rowspan="1" colspan="1">0.005</td>
								<td rowspan="1" colspan="1">9</td>
								<td rowspan="1" colspan="1">1.329 (0.924-1.912)</td>
								<td rowspan="1" colspan="1">0.009</td>
								<td rowspan="1" colspan="1">9</td>
								<td rowspan="1" colspan="1">1.353 (1.115-1.642)*</td>
								<td rowspan="1" colspan="1">0.435</td>
								<td rowspan="1" colspan="1">9</td>
								<td rowspan="1" colspan="1">1.135 (0.871-1.479)</td>
								<td rowspan="1" colspan="1">0.044</td>
								<td rowspan="1" colspan="1">9</td>
								<td rowspan="1" colspan="1">1.362(1.134,1.635)*</td>
								<td rowspan="1" colspan="1">0.116</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Population based</td>
								<td rowspan="1" colspan="1">14</td>
								<td rowspan="1" colspan="1">1.021 (0.941-1.107)</td>
								<td rowspan="1" colspan="1">0.124</td>
								<td rowspan="1" colspan="1">14</td>
								<td rowspan="1" colspan="1">1.012 (0.832-1.231)</td>
								<td rowspan="1" colspan="1">0.196</td>
								<td rowspan="1" colspan="1">14</td>
								<td rowspan="1" colspan="1">1.165 (1.024-1.327)*</td>
								<td rowspan="1" colspan="1">0.189</td>
								<td rowspan="1" colspan="1">14</td>
								<td rowspan="1" colspan="1">0.911 (0.764-1.087)</td>
								<td rowspan="1" colspan="1">0.154</td>
								<td rowspan="1" colspan="1">14</td>
								<td rowspan="1" colspan="1">1.114(0.986,1.258)</td>
								<td rowspan="1" colspan="1">0.190</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Sample size</td>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Small</td>
								<td rowspan="1" colspan="1">18</td>
								<td rowspan="1" colspan="1">1.092 (0.955-1.249)</td>
								<td rowspan="1" colspan="1">&lt;0.001</td>
								<td rowspan="1" colspan="1">18</td>
								<td rowspan="1" colspan="1">1.149 (0.896-1.472)</td>
								<td rowspan="1" colspan="1">0.008</td>
								<td rowspan="1" colspan="1">18</td>
								<td rowspan="1" colspan="1">1.223 (1.036-1.445)*</td>
								<td rowspan="1" colspan="1">0.085</td>
								<td rowspan="1" colspan="1">18</td>
								<td rowspan="1" colspan="1">1.006 (0.813-1.246)</td>
								<td rowspan="1" colspan="1">0.008</td>
								<td rowspan="1" colspan="1">18</td>
								<td rowspan="1" colspan="1">1.200 (1.006-1.430)*</td>
								<td rowspan="1" colspan="1">0.016</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Large</td>
								<td rowspan="1" colspan="1">5</td>
								<td rowspan="1" colspan="1">1.032 (0.918-1.161)</td>
								<td rowspan="1" colspan="1">0.269</td>
								<td rowspan="1" colspan="1">5</td>
								<td rowspan="1" colspan="1">1.051 (0.836-1.320)</td>
								<td rowspan="1" colspan="1">0.313</td>
								<td rowspan="1" colspan="1">5</td>
								<td rowspan="1" colspan="1">1.134 (0.863-1.490)</td>
								<td rowspan="1" colspan="1">0.042</td>
								<td rowspan="1" colspan="1">5</td>
								<td rowspan="1" colspan="1">0.980 (0.824-1.164)</td>
								<td rowspan="1" colspan="1">0.810</td>
								<td rowspan="1" colspan="1">5</td>
								<td rowspan="1" colspan="1">1.107 (0.862-1.421)</td>
								<td rowspan="1" colspan="1">0.052</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Cancer types</td>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
								<td rowspan="1" colspan="1"/>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Prostate cancer</td>
								<td rowspan="1" colspan="1">2</td>
								<td rowspan="1" colspan="1">0.993 (0.852-1.157)</td>
								<td rowspan="1" colspan="1">0.385</td>
								<td rowspan="1" colspan="1">2</td>
								<td rowspan="1" colspan="1">0.993 (0.732-1.346)</td>
								<td rowspan="1" colspan="1">0.331</td>
								<td rowspan="1" colspan="1">2</td>
								<td rowspan="1" colspan="1">1.039 (0.639-1.690)</td>
								<td rowspan="1" colspan="1">0.081</td>
								<td rowspan="1" colspan="1">2</td>
								<td rowspan="1" colspan="1">0.985 (0.773-1.254)</td>
								<td rowspan="1" colspan="1">0.896</td>
								<td rowspan="1" colspan="1">2</td>
								<td rowspan="1" colspan="1">1.027 (0.675-1.565)</td>
								<td rowspan="1" colspan="1">0.109</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Esophageal cancer</td>
								<td rowspan="1" colspan="1">2</td>
								<td rowspan="1" colspan="1">1.095 (0.926-1.293)</td>
								<td rowspan="1" colspan="1">0.852</td>
								<td rowspan="1" colspan="1">2</td>
								<td rowspan="1" colspan="1">1.111 (0.799-1.544)</td>
								<td rowspan="1" colspan="1">0.783</td>
								<td rowspan="1" colspan="1">2</td>
								<td rowspan="1" colspan="1">1.371 (1.045-1.800)*</td>
								<td rowspan="1" colspan="1">0.528</td>
								<td rowspan="1" colspan="1">2</td>
								<td rowspan="1" colspan="1">0.945 (0.713-1.253)</td>
								<td rowspan="1" colspan="1">0.591</td>
								<td rowspan="1" colspan="1">2</td>
								<td rowspan="1" colspan="1">1.289 (1.002-1.658)*</td>
								<td rowspan="1" colspan="1">0.700</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Nasopharyngeal carcinoma</td>
								<td rowspan="1" colspan="1">4</td>
								<td rowspan="1" colspan="1">1.144 (0.985-1.328)</td>
								<td rowspan="1" colspan="1">0.845</td>
								<td rowspan="1" colspan="1">4</td>
								<td rowspan="1" colspan="1">1.305 (0.961-1.772)</td>
								<td rowspan="1" colspan="1">0.759</td>
								<td rowspan="1" colspan="1">4</td>
								<td rowspan="1" colspan="1">1.330 (1.029-1.719)*</td>
								<td rowspan="1" colspan="1">0.704</td>
								<td rowspan="1" colspan="1">4</td>
								<td rowspan="1" colspan="1">1.082 (0.842-1.391)</td>
								<td rowspan="1" colspan="1">0.547</td>
								<td rowspan="1" colspan="1">4</td>
								<td rowspan="1" colspan="1">1.323 (1.037-1.687)*</td>
								<td rowspan="1" colspan="1">0.823</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Colorectal cancer</td>
								<td rowspan="1" colspan="1">3</td>
								<td rowspan="1" colspan="1">1.066 (0.883-1.286)</td>
								<td rowspan="1" colspan="1">0.262</td>
								<td rowspan="1" colspan="1">3</td>
								<td rowspan="1" colspan="1">1.092 (0.664-1.795)</td>
								<td rowspan="1" colspan="1">0.213</td>
								<td rowspan="1" colspan="1">3</td>
								<td rowspan="1" colspan="1">1.460 (0.898-2.371)</td>
								<td rowspan="1" colspan="1">0.097</td>
								<td rowspan="1" colspan="1">3</td>
								<td rowspan="1" colspan="1">0.896 (0.638-1.259)</td>
								<td rowspan="1" colspan="1">0.359</td>
								<td rowspan="1" colspan="1">3</td>
								<td rowspan="1" colspan="1">1.337 (0.865-2.068)</td>
								<td rowspan="1" colspan="1">0.118</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Breast cancer</td>
								<td rowspan="1" colspan="1">2</td>
								<td rowspan="1" colspan="1">1.147 (0.904-1.456)</td>
								<td rowspan="1" colspan="1">0.726</td>
								<td rowspan="1" colspan="1">2</td>
								<td rowspan="1" colspan="1">1.332 (0.800-2.216)</td>
								<td rowspan="1" colspan="1">0.438</td>
								<td rowspan="1" colspan="1">2</td>
								<td rowspan="1" colspan="1">1.169 (0.814-1.678)</td>
								<td rowspan="1" colspan="1">0.532</td>
								<td rowspan="1" colspan="1">2</td>
								<td rowspan="1" colspan="1">1.225 (0.716-2.096)</td>
								<td rowspan="1" colspan="1">0.274</td>
								<td rowspan="1" colspan="1">2</td>
								<td rowspan="1" colspan="1">1.204 (0.854-1.696)</td>
								<td rowspan="1" colspan="1">0.784</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Cervical cancer</td>
								<td rowspan="1" colspan="1">2</td>
								<td rowspan="1" colspan="1">1.396 (0.208-9.382)</td>
								<td rowspan="1" colspan="1">&lt;0.001</td>
								<td rowspan="1" colspan="1">2</td>
								<td rowspan="1" colspan="1">1.890 (0.069-51.901)</td>
								<td rowspan="1" colspan="1">&lt;0.001</td>
								<td rowspan="1" colspan="1">2</td>
								<td rowspan="1" colspan="1">1.397 (0.644-3.031)</td>
								<td rowspan="1" colspan="1">0.241</td>
								<td rowspan="1" colspan="1">2</td>
								<td rowspan="1" colspan="1">1.403 (0.090-21.882)</td>
								<td rowspan="1" colspan="1">&lt;0.001</td>
								<td rowspan="1" colspan="1">2</td>
								<td rowspan="1" colspan="1">1.653 (0.241-11.339)</td>
								<td rowspan="1" colspan="1">0.003</td>
							</tr>
							<tr>
								<td rowspan="1" colspan="1">Other cancers</td>
								<td rowspan="1" colspan="1">8</td>
								<td rowspan="1" colspan="1">1.044 (0.910-1.196)</td>
								<td rowspan="1" colspan="1">0.200</td>
								<td rowspan="1" colspan="1">8</td>
								<td rowspan="1" colspan="1">0.978 (0.717-1.334)</td>
								<td rowspan="1" colspan="1">0.223</td>
								<td rowspan="1" colspan="1">8</td>
								<td rowspan="1" colspan="1">1.100 (0.803-1.507)</td>
								<td rowspan="1" colspan="1">0.014</td>
								<td rowspan="1" colspan="1">8</td>
								<td rowspan="1" colspan="1">0.935 (0.738-1.183)</td>
								<td rowspan="1" colspan="1">0.804</td>
								<td rowspan="1" colspan="1">8</td>
								<td rowspan="1" colspan="1">1.075 (0.795-1.454)</td>
								<td rowspan="1" colspan="1">0.012</td>
							</tr>
						</tbody>
					</table>
					<table-wrap-foot>
						<fn>
							<p>OR: odds ratio; CI: confidence intervals; Phet: P value for heterogeneity; * OR with statistical significance</p>
						</fn>
					</table-wrap-foot>
				</table-wrap>
			</sec>
			<sec id="s3.3">
				<title>Subgroup analyses, sensitivity analysis and cumulative meta-analysis</title>
				<p>In a stratified analysis by specific cancer types, <named-content content-type="gene" xlink:type="simple">-607C/A</named-content> polymorphisms in IL-18 gene promoter was significantly associated with an increased risk of nasopharyngeal carcinoma (CA vs CC:OR =1.330, 95% CI: 1.029,1.719; P<sub>heterogeneity</sub>=0.704; <named-content content-type="gene" xlink:type="simple">AA/CA</named-content> vs. CC:OR =1.323, 95% CI: 1.037,1.687; P<sub>heterogeneity</sub>=0.823) and esophageal cancer(CA vs CC:OR =1.371, 95% CI: 1.045,1.800; P<sub>heterogeneity</sub>=0.528; <named-content content-type="gene" xlink:type="simple">AA/CA</named-content> vs. CC:OR =1.289, 95% CI: 1.002,1.658; P<sub>heterogeneity</sub>=0.700) in the heterozygous model and dominant model. No evidence of association was found in any genetic model between-607C/A polymorphisms in IL-18 gene promoter and the risk of prostate cancer, colorectal cancer, breast cancer, cervical cancer, and other cancers(shown in <xref ref-type="table" rid="pone-0076915-t002">Table 2</xref>). According to ethnicity, the polymorphism presented a significantly increased risk of cancer among Asian population in the heterozygous model and dominant model(CA vs CC:OR =1.191, 95% CI: 1.047,1.356; P<sub>heterogeneity</sub>=0.487; <named-content content-type="gene" xlink:type="simple">AA/CA</named-content> vs. CC:OR =1.197, 95% CI: 1.023,1.401; P<sub>heterogeneity</sub>=0.088); however, no significant association was found in Caucasian and African population (shown in <xref ref-type="table" rid="pone-0076915-t002">Table 2</xref>). In the stratified analysis by source of control groups, we found that the <named-content content-type="gene" xlink:type="simple">-607C/A</named-content> polymorphisms in IL-18 gene promoter was associated with a significantly increased risk in hospital-based controls in the allelic model (A vs C:OR =1.247, 95% CI: 1.022, 1.523; P<sub>heterogeneity</sub>=0.005), heterozygous model(A vs C:OR =1.353, 95% CI: 1.115, 1.642; P<sub>heterogeneity</sub>=0.435), and dominant model(A vs C:OR =1.362, 95% CI: 1.134,1.635; P<sub>heterogeneity</sub>=0.116). However, among studies with population-based controls, a significant association was only observed in heterozygous model(A vs C:OR =1.165, 95% CI: 1.024, 1.327; P<sub>heterogeneity</sub>=0.189). When stratifying the sample size, a significant association was observed among studies with small sample size in the heterozygous model and dominant model (CA vs CC:OR =1.223, 95% CI: 1.036,1.445; P<sub>heterogeneity</sub>=0.085; <named-content content-type="gene" xlink:type="simple">AA/CA</named-content> vs. CC:OR =1.200, 95% CI: 1.006,1.430; P<sub>heterogeneity</sub>=0.016), but not observed among studies with large sample size in any genetic models. To test the robustness of association, sensitivity analysis was carried out by excluding studies one-by-one and analyzing effect size for all of rest studies. Sensitivity analysis indicated that no significant variation in combined RR by excluding any of the study, confirming the stability of present results. Cumulative meta-analyses were carried out in the heterozygous and dominant genetic models. Between 2006 and 2013, with each accumulation of more studies, the 95% CIs for the pooled ORs became increasingly narrower, indicating that the precision of the estimation was progressively boosted by continually adding more samples(shown in <xref ref-type="fig" rid="pone-0076915-g004">Figure 4</xref>).</p>
				<fig id="pone-0076915-g004" position="float">
					<object-id pub-id-type="doi">10.1371/journal.pone.0076915.g004</object-id><label>Figure 4</label>
					<caption>
						<title>Cumulative meta-analysis of association between <named-content content-type="gene" xlink:type="simple">-607C/A</named-content> polymorphisms in IL-18 gene promoter and cancer risk under the heterozygous model(CA vs. CC).</title>
					</caption>
					<graphic xlink:type="simple" position="float" xlink:href="info:doi/10.1371/journal.pone.0076915.g004"/>
				</fig>
			</sec>
			<sec id="s3.4">
				<title>Meta-regression and Publication bias</title>
				<p>As shown in <xref ref-type="table" rid="pone-0076915-t002">Table 2</xref>, significant heterogeneity was present in all models except for heterozygous model, hence, meta-regression was conducted to detect the source of heterogeneity. Ethnicity, source of controls, sample size and cancer type, which may be potential sources of heterogeneity, were tested by a meta-regression method. The results showed that, in the dominant model (<named-content content-type="gene" xlink:type="simple">AA/CA</named-content> vs. CC) for instance, the heterogeneity could only be explained by cancer type(p=0.014), but not ethnicity, sample size, or the source of controls. The potential publication bias of the literatures was evaluated by funnel plot and Egger’s test. No visual publication bias was found in the funnel plot (<xref ref-type="fig" rid="pone-0076915-g005">Figure 5</xref>). And Egger’s test suggested that no publication bias was detected in all the comparison models (P &gt;0.05)</p>
				<fig id="pone-0076915-g005" position="float">
					<object-id pub-id-type="doi">10.1371/journal.pone.0076915.g005</object-id><label>Figure 5</label>
					<caption>
						<title>Funnel plot for publication bias in the studies investigating the association between <named-content content-type="gene" xlink:type="simple">-607C/A</named-content> polymorphisms in IL-18 gene promoter and risk of cancer(heterozygous genetic model: CA vs. CC).</title>
						<p>No publication bias was observed among studies using Begg’s P value (P = 0.167) and Egger’s (P = 0.387) test, which suggested there was no evidence of publication bias.</p>
					</caption>
					<graphic xlink:type="simple" position="float" xlink:href="info:doi/10.1371/journal.pone.0076915.g005"/>
				</fig>
			</sec>
		</sec>
		<sec id="s4" sec-type="discussion">
			<title>Discussion</title>
			<p>The present meta-analysis, which included 4100 cancer cases and 4327 controls from 21 publications with 22 case-control studies, explored the relationship between <named-content content-type="gene" xlink:type="simple">-607C/A</named-content> polymorphisms in IL-18 gene promoter and cancer risk. For overall comparison of pooled ORs, significantly increased risk was observed in the heterozygous model(CA vs CC) and the dominant model(<named-content content-type="gene" xlink:type="simple">AA/CA</named-content> vs. CC). Under the allelic, homozygous and recessive genetic models, there was no significant association between <named-content content-type="gene" xlink:type="simple">-607C/A</named-content> polymorphisms in IL-18 gene promoter and cancer risk. Overall, a significant association exists between <named-content content-type="gene" xlink:type="simple">-607C/A</named-content> polymorphisms in IL-18 gene promoter and cancer risk. This finding indicates that the genetic variant in IL-18 gene promoter region may crucially modify the susceptibility of cancers. The C to A substitution at position −607 disrupts a consensus cAMP-responsive element protein-binding site, causing altered transcription factor binding and gene expression [<xref ref-type="bibr" rid="B9">9</xref>]. IL-18 serum levels have been reported to be elevated in a variety of cancers compared with control group [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B36">36</xref>-<xref ref-type="bibr" rid="B39">39</xref>]. Hence, the <named-content content-type="gene" xlink:type="simple">-607C/A</named-content> polymorphisms in IL-18 gene promoter may modify the susceptibility of cancers though changing the expression of IL-18 gene. The mechanism needs further investigation.</p>
			<p>When identifying eligible studies by reading full text, the study conducted by Jaiswal PK and colleagues [<xref ref-type="bibr" rid="B40">40</xref>] was excluded for incorrect data. The OR and 95% CI under heterozygous genetic model (OR =0.59, 95% CI: 0.39, 0.92)we got based on the genotype frequency in cases and controls(CC: 81, CA: 89 in cases; CC: 61, CA: 113 in controls) were totally opposed to that they got(OR =1.59, 95% CI: 1.01-2.95). Hence, we excluded this study for its unbelievable result.</p>
			<p>In the stratified analysis based on ethnicity, a significant increased risk of cancer was found in Asian population, but not in Caucasian or African population. One probable reason is that different environment they live in and different genetic backgrounds may account for these differences. As we know, different populations carry different genotype and/or allele frequencies of this locus polymorphism and may lead to various degrees of cancer susceptibility [<xref ref-type="bibr" rid="B41">41</xref>]. And different ethnic groups live with multiple life styles and environmental factors and thus yield diverse gene-environment interactions [<xref ref-type="bibr" rid="B42">42</xref>]. In addition, there are only one study and five studies investigating the association between <named-content content-type="gene" xlink:type="simple">-607C/A</named-content> polymorphisms in IL-18 gene promoter and cancer risk among African and Caucasian population, respectively. Insufficient number of patients limited us to detect stable effects in these two populations. Additional studies are warranted to further validate ethnic difference in the effect of <named-content content-type="gene" xlink:type="simple">-607C/A</named-content> polymorphisms in IL-18 gene promoter on cancer risk, especially in Africans. During sub-group analyses, we found that the source of controls also affected the association between <named-content content-type="gene" xlink:type="simple">-607C/A</named-content> polymorphisms in IL-18 gene promoter and cancer risk. A significant association was observed in hospital-based controls under allelic and dominant genetic models, but not the population-based controls. The reason may be that the hospital-based studies have some inherent selection biases as such controls may just represent a sample of ill-defined reference population and may not be very representative of the study population or the general population. In stratified analysis by cancer site, we found that <named-content content-type="gene" xlink:type="simple">-607C/A</named-content> polymorphisms in IL-18 gene promoter was statistically related with an increased risk of esophageal cancer and nasopharyngeal carcinoma. However, no evidence of association was found in any genetic model between-607C/A polymorphisms in IL-18 gene promoter and the risk of prostate cancer, colorectal cancer, breast cancer, cervical cancer, or other cancers. One possible reason is that carcinogenic mechanism underlying the etiology may differ by different tumor sites and that the <named-content content-type="gene" xlink:type="simple">-607C/A</named-content> polymorphisms in IL-18 gene promoter may play a different role in different cancers. Futher, the number of studies which investigated the association between <named-content content-type="gene" xlink:type="simple">-607C/A</named-content> polymorphisms in IL-18 gene promoter and risk of different types of cancer was too small(≤3), which limited us to detect stable effects on different cancer types. So, more studies focusing on different cancer types are need in the future.</p>
			<p>The strength of the present analysis lies in inclusion of 22 studies, reporting data of 4100 cancer cases and 4327 controls. Publication bias, which, due to the tendency of not publishing small studies with null results, was not found in our meta-analysis. Furthermore, our findings were stable and robust in sensitivity analyses. Cumulative meta-analyses showed that, with each accumulation of more studies, the 95% CIs for the pooled ORs became increasingly narrower, indicating that the precision of the estimation was progressively boosted by continually adding more samples. Some limitations might be included in the meta-analysis. Firstly, we did not search for unpublished studies, so only published studies were included in our meta-analysis. Therefore, publication bias may have occurred although no publication bias was indicated from both visualization of the funnel plot and Egger’s test. Secondly, the results were based on unadjusted ORs, while a more precise estimation should take into account the effect of multiple confounders such as age, smoking status, drinking status and environmental factors on the association. Lack of information for data analysis may cause serious confounding bias. Thirdly, the small sample size is the major defect in this meta-analysis. In the stratified analysis by ethnicity and cancer type, the sample size of studies among Caucasians, Africans and among several cancer types is small, which limited us to detect stable effects in these populations and cancer types. Further studies are warranted to further evaluate the association in different ethnicities and cancer types in the future. Additionally, heterogeneity was significant in our meta-analysis, which may attenuate the strength of this study.</p>
			<p>In conclusion, the present meta-analysis suggests that the <named-content content-type="gene" xlink:type="simple">-607C/A</named-content> polymorphisms in IL-18 gene promoter is associated with a significantly increased risk of cancer, especially for nasopharyngeal carcinoma and esophageal cancer and in Asian population. More studies with larger sample size, well controlled confounding factors are warranted to further evaluate the association in different ethnicities and different cancer types in the future.</p>
		</sec>
		<sec sec-type="supplementary-material">
			<title>Supporting Information</title><supplementary-material xlink:type="simple" position="float" id="pone.0076915.s001" xlink:href="info:doi/10.1371/journal.pone.0076915.s001" mimetype="application/msword">
				<label>Checklist S1</label>
				<caption>
					<p><bold>PRISMA checklist.</bold>
				</p><p>(DOC)</p></caption>
				</supplementary-material>
		</sec>
	</body>
	<back>
		<ref-list>
			<title>References</title>
			<ref id="B1">
				<label>1</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bazan</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Timans</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Kastelein</surname><given-names>RA</given-names></name> (<year>1996</year>) <article-title>A newly defined interleukin-1?</article-title> <source>Nature</source> <volume>379</volume>: <fpage>591</fpage>. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/379591a0" xlink:type="simple">10.1038/379591a0</ext-link>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/8628393" xlink:type="simple">8628393</ext-link>.</mixed-citation>
			</ref>
			<ref id="B2">
				<label>2</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dinarello</surname><given-names>CA</given-names></name> (<year>1999</year>) <article-title>Interleukin-18</article-title>. <source>Methods</source> <volume>19</volume>: <fpage>121</fpage>-<lpage>132</lpage>. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1006/meth.1999.0837" xlink:type="simple">10.1006/meth.1999.0837</ext-link>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/10525448" xlink:type="simple">10525448</ext-link>.</mixed-citation>
			</ref>
			<ref id="B3">
				<label>3</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Baxevanis</surname><given-names>CN</given-names></name>, <name name-style="western"><surname>Gritzapis</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Papamichail</surname><given-names>M</given-names></name> (<year>2003</year>) <article-title>In vivo antitumor activity of NKT cells activated by the combination of IL-12 and IL-18</article-title>. <source>J Immunol</source> <volume>171</volume>: <fpage>2953</fpage>-<lpage>2959</lpage>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/12960319" xlink:type="simple">12960319</ext-link>.</mixed-citation>
			</ref>
			<ref id="B4">
				<label>4</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lebel-Binay</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Berger</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Zinzindohoué</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Cugnenc</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Thiounn</surname><given-names>N</given-names></name> <etal>et al.</etal> (<year>2000</year>) <article-title>Interleukin-18: biological properties and clinical implications</article-title>. <source>Eur Cytokine Netw</source> <volume>11</volume>: <fpage>15</fpage>-<lpage>26</lpage>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/10705295" xlink:type="simple">10705295</ext-link>.</mixed-citation>
			</ref>
			<ref id="B5">
				<label>5</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tschoeke</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Oberholzer</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Moldawer</surname><given-names>LL</given-names></name> (<year>2006</year>) <article-title>Interleukin-18: a novel prognostic cytokine in bacteria-induced sepsis</article-title>. <source>Crit Care Med</source> <volume>34</volume>: <fpage>1225</fpage>-<lpage>1233</lpage>. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/01.CCM.0000208356.05575.16" xlink:type="simple">10.1097/01.CCM.0000208356.05575.16</ext-link>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/16540967" xlink:type="simple">16540967</ext-link>.</mixed-citation>
			</ref>
			<ref id="B6">
				<label>6</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sims</surname><given-names>JE</given-names></name> (<year>2002</year>) <article-title>IL-1 and IL-18 receptors, and their extended family</article-title>. <source>Curr Opin Immunol</source> <volume>14</volume>: <fpage>117</fpage>-<lpage>122</lpage>. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0952-7915(01)00306-5" xlink:type="simple">10.1016/S0952-7915(01)00306-5</ext-link>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/11790541" xlink:type="simple">11790541</ext-link>.</mixed-citation>
			</ref>
			<ref id="B7">
				<label>7</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vidal-Vanaclocha</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Mendoza</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Telleria</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Salado</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Valcárcel</surname><given-names>M</given-names></name> <etal>et al.</etal> (<year>2006</year>) <article-title>Clinical and experimental approaches to the pathophysiology of interleukin-18 in cancer progression</article-title>. <source>Cancer Metastasis Rev</source> <volume>25</volume>: <fpage>417</fpage>-<lpage>434</lpage>. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s10555-006-9013-3" xlink:type="simple">10.1007/s10555-006-9013-3</ext-link>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/17001512" xlink:type="simple">17001512</ext-link>.</mixed-citation>
			</ref>
			<ref id="B8">
				<label>8</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tsuboi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Miyazaki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Nakajima</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Fukai</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Masuda</surname><given-names>N</given-names></name> <etal>et al.</etal> (<year>2004</year>) <article-title>Serum interleukin-12 and interleukin-18 levels as a tumor marker in patients with esophageal carcinoma</article-title>. <source>Cancer Lett</source> <volume>205</volume>: <fpage>207</fpage>-<lpage>214</lpage>. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.canlet.2003.10.010" xlink:type="simple">10.1016/j.canlet.2003.10.010</ext-link>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/15036653" xlink:type="simple">15036653</ext-link>.</mixed-citation>
			</ref>
			<ref id="B9">
				<label>9</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Giedraitis</surname><given-names>V</given-names></name>, <name name-style="western"><surname>He</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>WX</given-names></name>, <name name-style="western"><surname>Hillert</surname><given-names>J</given-names></name> (<year>2001</year>) <article-title>Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation</article-title>. <source>J Neuroimmunol</source> <volume>112</volume>: <fpage>146</fpage>-<lpage>152</lpage>. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0165-5728(00)00407-0" xlink:type="simple">10.1016/S0165-5728(00)00407-0</ext-link>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/11108943" xlink:type="simple">11108943</ext-link>.</mixed-citation>
			</ref>
			<ref id="B10">
				<label>10</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pratesi</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bortolin</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Bidoli</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Tedeschi</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Vaccher</surname><given-names>E</given-names></name> <etal>et al.</etal> (<year>2006</year>) <article-title>Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type</article-title>. <source>Cancer Immunol Immunother</source> <volume>55</volume>: <fpage>23</fpage>-<lpage>30</lpage>. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00262-005-0688-z" xlink:type="simple">10.1007/s00262-005-0688-z</ext-link>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/16059673" xlink:type="simple">16059673</ext-link>.</mixed-citation>
			</ref>
			<ref id="B11">
				<label>11</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Farjadfar</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mojtahedi</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Ghayumi</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Erfani</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Haghshenas</surname><given-names>MR</given-names></name> <etal>et al.</etal> (<year>2009</year>) <article-title>Interleukin-18 promoter polymorphism is associated with lung cancer: a case-control study</article-title>. <source>Acta Oncol</source> <volume>48</volume>: <fpage>971</fpage>-<lpage>976</lpage>. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1080/02841860902878145" xlink:type="simple">10.1080/02841860902878145</ext-link>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/19642044" xlink:type="simple">19642044</ext-link>.</mixed-citation>
			</ref>
			<ref id="B12">
				<label>12</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Taheri</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hashemi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Eskandari-Nasab</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Fazaeli</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Arababi</surname><given-names>F</given-names></name> <etal>et al.</etal> (<year>2012</year>) <article-title>Association of -607 C/A polymorphism of IL-18 gene (rs1946518) with breast cancer risk in Zahedan, Southeast Iran</article-title>. <source>Prague Med Rep</source> <volume>113</volume>: <fpage>217</fpage>-<lpage>222</lpage>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/22980562" xlink:type="simple">22980562</ext-link>.</mixed-citation>
			</ref>
			<ref id="B13">
				<label>13</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Asefi</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Mojtahedi</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Khademi</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Naeimi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ghaderi</surname><given-names>A</given-names></name> (<year>2009</year>) <article-title>Head and neck squamous cell carcinoma is not associated with interleukin-18 promoter gene polymorphisms: a case-control study</article-title>. <source>J Laryngol Otol</source> <volume>123</volume>: <fpage>444</fpage>-<lpage>448</lpage>. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1017/S0022215108003733" xlink:type="simple">10.1017/S0022215108003733</ext-link>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/18940019" xlink:type="simple">18940019</ext-link>.</mixed-citation>
			</ref>
			<ref id="B14">
				<label>14</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lau</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ioannidis</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Schmid</surname><given-names>CH</given-names></name> (<year>1997</year>) <article-title>Quantitative synthesis in systematic reviews</article-title>. <source>Ann Intern Med</source> <volume>127</volume>: <fpage>820</fpage>-<lpage>826</lpage>. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.7326/0003-4819-127-9-199711010-00008" xlink:type="simple">10.7326/0003-4819-127-9-199711010-00008</ext-link>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/9382404" xlink:type="simple">9382404</ext-link>.</mixed-citation>
			</ref>
			<ref id="B15">
				<label>15</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DerSimonian</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Laird</surname><given-names>N</given-names></name> (<year>1986</year>) <article-title>Meta-analysis in clinical trials</article-title>. <source>Control Clin Trials</source> <volume>7</volume>: <fpage>177</fpage>-<lpage>188</lpage>. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/0197-2456(86)90046-2" xlink:type="simple">10.1016/0197-2456(86)90046-2</ext-link>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/3802833" xlink:type="simple">3802833</ext-link>.</mixed-citation>
			</ref>
			<ref id="B16">
				<label>16</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higgins</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>SG</given-names></name> (<year>2004</year>) <article-title>Controlling the risk of spurious findings from meta-regression</article-title>. <source>Stat Med</source> <volume>23</volume>: <fpage>1663</fpage>-<lpage>1682</lpage>. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/sim.1752" xlink:type="simple">10.1002/sim.1752</ext-link>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/15160401" xlink:type="simple">15160401</ext-link>.</mixed-citation>
			</ref>
			<ref id="B17">
				<label>17</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Begg</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Mazumdar</surname><given-names>M</given-names></name> (<year>1994</year>) <article-title>Operating characteristics of a rank correlation test for publication bias</article-title>. <source>Biometrics</source> <volume>50</volume>: <fpage>1088</fpage>-<lpage>1101</lpage>. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2307/2533446" xlink:type="simple">10.2307/2533446</ext-link>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/7786990" xlink:type="simple">7786990</ext-link>.</mixed-citation>
			</ref>
			<ref id="B18">
				<label>18</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Egger</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Davey Smith</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Schneider</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Minder</surname><given-names>C</given-names></name> (<year>1997</year>) <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>BMJ</source> <volume>315</volume>: <fpage>629</fpage>-<lpage>634</lpage>. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/bmj.315.7109.629" xlink:type="simple">10.1136/bmj.315.7109.629</ext-link>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/9310563" xlink:type="simple">9310563</ext-link>.</mixed-citation>
			</ref>
			<ref id="B19">
				<label>19</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Haghshenas</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Hosseini</surname><given-names>SV</given-names></name>, <name name-style="western"><surname>Mahmoudi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Saberi-Firozi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Farjadian</surname><given-names>S</given-names></name> <etal>et al.</etal> (<year>2009</year>) <article-title>IL-18 serum level and IL-18 promoter gene polymorphism in Iranian patients with gastrointestinal cancers</article-title>. <source>J Gastroenterol Hepatol</source> <volume>24</volume>: <fpage>1119</fpage>-<lpage>1122</lpage>. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1440-1746.2009.05791.x" xlink:type="simple">10.1111/j.1440-1746.2009.05791.x</ext-link>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/19638090" xlink:type="simple">19638090</ext-link>.</mixed-citation>
			</ref>
			<ref id="B20">
				<label>20</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Babar</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ryan</surname><given-names>AW</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Segurado</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Turner</surname><given-names>G</given-names></name> <etal>et al.</etal> (<year>2012</year>) <article-title>Genes of the interleukin-18 pathway are associated with susceptibility to Barrett’s esophagus and esophageal adenocarcinoma</article-title>. <source>Am J Gastroenterol</source> <volume>107</volume>: <fpage>1331</fpage>-<lpage>1341</lpage>. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ajg.2012.134" xlink:type="simple">10.1038/ajg.2012.134</ext-link>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/22664470" xlink:type="simple">22664470</ext-link>.</mixed-citation>
			</ref>
			<ref id="B21">
				<label>21</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Du</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>Y</given-names></name> (<year>2012</year>) <article-title>Interleukin-18 genegenetic polymorphisms and risk of nasopharyngeaI carcinomain in Han population from Sichuan China. Med</article-title>. <source>J West China</source> <volume>24</volume>: <fpage>1683</fpage>-<lpage>1685</lpage>.</mixed-citation>
			</ref>
			<ref id="B22">
				<label>22</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Farhat</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Hassen</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Bouzgarrou</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Gabbouj</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bouaouina</surname><given-names>N</given-names></name> <etal>et al.</etal> (<year>2008</year>) <article-title>Functional IL-18 promoter gene polymorphisms in Tunisian nasopharyngeal carcinoma patients</article-title>. <source>Cytokine</source> <volume>43</volume>: <fpage>132</fpage>-<lpage>137</lpage>. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.cyto.2008.05.004" xlink:type="simple">10.1016/j.cyto.2008.05.004</ext-link>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/18555694" xlink:type="simple">18555694</ext-link>.</mixed-citation>
			</ref>
			<ref id="B23">
				<label>23</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Guo</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Qin</surname><given-names>AQ</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>RK</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>FD</given-names></name> <etal>et al.</etal> (<year>2012</year>) <article-title>[Association of the IL-18 gene polymorphism with susceptibility to colorectal cancer]</article-title>. <source>Zhonghua Wei Chang Wai Ke Za Zhi</source> <volume>15</volume>: <fpage>400</fpage>-<lpage>403</lpage>.</mixed-citation>
			</ref>
			<ref id="B24">
				<label>24</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kashef</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Dehaghani</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Naeimi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Fattahi</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Ghaderi</surname><given-names>A</given-names></name> (<year>2008</year>) <article-title>Interleukin-18 gene promoter polymorphisms in women with gestational trophoblastic diseases</article-title>. <source>J Reprod Med</source> <volume>53</volume>: <fpage>853</fpage>-<lpage>859</lpage>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/19097518" xlink:type="simple">19097518</ext-link>.</mixed-citation>
			</ref>
			<ref id="B25">
				<label>25</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Khalili-Azad</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Razmkhah</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ghiam</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Doroudchi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Talei</surname><given-names>AR</given-names></name> <etal>et al.</etal> (<year>2009</year>) <article-title>Association of interleukin-18 gene promoter polymorphisms with breast cancer</article-title>. <source>Neoplasma</source> <volume>56</volume>: <fpage>22</fpage>-<lpage>25</lpage>. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4149/neo_2009_01_22" xlink:type="simple">10.4149/neo_2009_01_22</ext-link>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/19152241" xlink:type="simple">19152241</ext-link>.</mixed-citation>
			</ref>
			<ref id="B26">
				<label>26</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>JN</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>He</surname><given-names>YZ</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name> <etal>et al.</etal> (<year>2013</year>) <article-title>Effect of IL-18 gene promoter polymorphisms on prostate cancer occurrence and prognosis in Han Chinese population</article-title>. <source>Genet Mol Res</source> <volume>12</volume>: <fpage>820</fpage>-<lpage>829</lpage>. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4238/2013.March.15.2" xlink:type="simple">10.4238/2013.March.15.2</ext-link>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/23546966" xlink:type="simple">23546966</ext-link>.</mixed-citation>
			</ref>
			<ref id="B27">
				<label>27</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Pang</surname><given-names>G</given-names></name> (<year>2007</year>) <article-title>Genetic polymorphisms of the interleukin-18 gene and risk of prostate cancer</article-title>. <source>DNA Cell Biol</source> <volume>26</volume>: <fpage>613</fpage>-<lpage>618</lpage>. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1089/dna.2007.0600" xlink:type="simple">10.1089/dna.2007.0600</ext-link>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/17688413" xlink:type="simple">17688413</ext-link>.</mixed-citation>
			</ref>
			<ref id="B28">
				<label>28</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nikiteas</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Yannopoulos</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Chatzitheofylaktou</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tsigris</surname><given-names>C</given-names></name> (<year>2007</year>) <article-title>Heterozygosity for interleukin-18 -607 A/C polymorphism is associated with risk for colorectal cancer</article-title>. <source>Anticancer Res</source> <volume>27</volume>: <fpage>3849</fpage>-<lpage>3853</lpage>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/18225542" xlink:type="simple">18225542</ext-link>.</mixed-citation>
			</ref>
			<ref id="B29">
				<label>29</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nong</surname><given-names>LG</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Nong</surname><given-names>HB</given-names></name> (<year>2009</year>) <article-title>Interleukin-18 gene promoter polymorphism and the risk of nasopharyngeal carcinoma in a Chinese population</article-title>. <source>DNA Cell Biol</source> <volume>28</volume>: <fpage>507</fpage>-<lpage>513</lpage>. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1089/dna.2009.0912" xlink:type="simple">10.1089/dna.2009.0912</ext-link>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/19622039" xlink:type="simple">19622039</ext-link>.</mixed-citation>
			</ref>
			<ref id="B30">
				<label>30</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Qi</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>HL</given-names></name>, <name name-style="western"><surname>Bao</surname><given-names>J</given-names></name> (<year>2008</year>) <article-title>[Correlation of serum IL-18 level and IL-18 gene promoter polymorphisms to the risk of cervical cancer]</article-title>. <source>NAN Fang Yi Ke Xue Xue Bao</source> <volume>28</volume>: <fpage>754</fpage>-<lpage>757</lpage>.</mixed-citation>
			</ref>
			<ref id="B31">
				<label>31</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sáenz-López</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Carretero</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Vazquez</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sánchez</surname><given-names>E</given-names></name> <etal>et al.</etal> (<year>2010</year>) <article-title>Impact of interleukin-18 polymorphisms-607 and -137 on clinical characteristics of renal cell carcinoma patients</article-title>. <source>Hum Immunol</source> <volume>71</volume>: <fpage>309</fpage>-<lpage>313</lpage>. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.humimm.2009.11.010" xlink:type="simple">10.1016/j.humimm.2009.11.010</ext-link>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/19961892" xlink:type="simple">19961892</ext-link>.</mixed-citation>
			</ref>
			<ref id="B32">
				<label>32</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Samsami Dehaghani</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Shahriary</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kashef</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Naeimi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Fattahi</surname><given-names>MJ</given-names></name> <etal>et al.</etal> (<year>2009</year>) <article-title>Interleukin-18 gene promoter and serum level in women with ovarian cancer</article-title>. <source>Mol Biol Rep</source> <volume>36</volume>: <fpage>2393</fpage>-<lpage>2397</lpage>. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s11033-009-9469-7" xlink:type="simple">10.1007/s11033-009-9469-7</ext-link>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/19263242" xlink:type="simple">19263242</ext-link>.</mixed-citation>
			</ref>
			<ref id="B33">
				<label>33</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vairaktaris</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Serefoglou</surname><given-names>ZC</given-names></name>, <name name-style="western"><surname>Yapijakis</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Agapi</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Vassiliou</surname><given-names>S</given-names></name> <etal>et al.</etal> (<year>2007</year>) <article-title>The interleukin-18 -607A/C polymorphism is not associated with risk for oral cancer</article-title>. <source>Anticancer Res</source> <volume>27</volume>: <fpage>4011</fpage>-<lpage>4014</lpage>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/18225563" xlink:type="simple">18225563</ext-link>.</mixed-citation>
			</ref>
			<ref id="B34">
				<label>34</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wei</surname><given-names>YS</given-names></name>, <name name-style="western"><surname>Lan</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>YG</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>RG</given-names></name> <etal>et al.</etal> (<year>2007</year>) <article-title>Interleukin-18 gene promoter polymorphisms and the risk of esophageal squamous cell carcinoma</article-title>. <source>Acta Oncol</source> <volume>46</volume>: <fpage>1090</fpage>-<lpage>1096</lpage>. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1080/02841860701373595" xlink:type="simple">10.1080/02841860701373595</ext-link>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/17851835" xlink:type="simple">17851835</ext-link>.</mixed-citation>
			</ref>
			<ref id="B35">
				<label>35</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yang</surname><given-names>HL</given-names></name>, <name name-style="western"><surname>Pin</surname><given-names>BH</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>W</given-names></name> <etal>et al.</etal> (<year>2007</year>) <article-title>[Association of interleukin-18 gene rs1946519 and rs360718 single nucleotide polymorphism with cervical cancer]</article-title>. <source>Nan Fang Yi Ke Da Xue Xue Bao</source> <volume>27</volume>: <fpage>1006</fpage>-<lpage>1008</lpage>.</mixed-citation>
			</ref>
			<ref id="B36">
				<label>36</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Günel</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Coşkun</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Sancak</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Günel</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Hasdemir</surname><given-names>O</given-names></name> <etal>et al.</etal> (<year>2002</year>) <article-title>Clinical importance of serum interleukin-18 and nitric oxide activities in breast carcinoma patients</article-title>. <source>Cancer</source> <volume>95</volume>: <fpage>663</fpage>-<lpage>667</lpage>. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/cncr.10705" xlink:type="simple">10.1002/cncr.10705</ext-link>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/12209760" xlink:type="simple">12209760</ext-link>.</mixed-citation>
			</ref>
			<ref id="B37">
				<label>37</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kawabata</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ichikura</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Majima</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Seki</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Chochi</surname><given-names>K</given-names></name> <etal>et al.</etal> (<year>2001</year>) <article-title>Preoperative serum interleukin-18 level as a postoperative prognostic marker in patients with gastric carcinoma</article-title>. <source>Cancer</source> <volume>92</volume>: <fpage>2050</fpage>-<lpage>2055</lpage>. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/1097-0142(20011015)92:8" xlink:type="simple">10.1002/1097-0142(20011015)92:8</ext-link>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/11596019" xlink:type="simple">11596019</ext-link>.</mixed-citation>
			</ref>
			<ref id="B38">
				<label>38</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Thong-Ngam</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Tangkijvanich</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Lerknimitr</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Mahachai</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Theamboonlers</surname><given-names>A</given-names></name> <etal>et al.</etal> (<year>2006</year>) <article-title>Diagnostic role of serum interleukin-18 in gastric cancer patients</article-title>. <source>World J Gastroenterol</source> <volume>12</volume>: <fpage>4473</fpage>-<lpage>4477</lpage>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/16874857" xlink:type="simple">16874857</ext-link>.</mixed-citation>
			</ref>
			<ref id="B39">
				<label>39</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bushley</surname><given-names>AW</given-names></name>, <name name-style="western"><surname>Ferrell</surname><given-names>R</given-names></name>, <name name-style="western"><surname>McDuffie</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Terada</surname><given-names>KY</given-names></name>, <name name-style="western"><surname>Carney</surname><given-names>ME</given-names></name> <etal>et al.</etal> (<year>2004</year>) <article-title>Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancer</article-title>. <source>Gynecol Oncol</source> <volume>95</volume>: <fpage>672</fpage>-<lpage>679</lpage>. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ygyno.2004.08.024" xlink:type="simple">10.1016/j.ygyno.2004.08.024</ext-link>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/15581980" xlink:type="simple">15581980</ext-link>.</mixed-citation>
			</ref>
			<ref id="B40">
				<label>40</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jaiswal</surname><given-names>PK</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Srivastava</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Mittal</surname><given-names>RD</given-names></name> (<year>2013</year>) <article-title>Association of IL-12, IL-18 variants and serum IL-18 with bladder cancer susceptibility in North Indian population</article-title>. <source>Gene</source> <volume>519</volume>: <fpage>128</fpage>-<lpage>134</lpage>. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.gene.2013.01.025" xlink:type="simple">10.1016/j.gene.2013.01.025</ext-link>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/23403235" xlink:type="simple">23403235</ext-link>.</mixed-citation>
			</ref>
			<ref id="B41">
				<label>41</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hirschhorn</surname><given-names>JN</given-names></name>, <name name-style="western"><surname>Lohmueller</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Byrne</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Hirschhorn</surname><given-names>K</given-names></name> (<year>2002</year>) <article-title>A comprehensive review of genetic association studies</article-title>. <source>Genet Med</source> <volume>4</volume>: <fpage>45</fpage>-<lpage>61</lpage>. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/00125817-200203000-00002" xlink:type="simple">10.1097/00125817-200203000-00002</ext-link>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/11882781" xlink:type="simple">11882781</ext-link>.</mixed-citation>
			</ref>
			<ref id="B42">
				<label>42</label>
				<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dick</surname><given-names>DM</given-names></name> (<year>2011</year>) <article-title>Gene-environment interaction in psychological traits and disorders</article-title>. <source>Annu Rev Clin Psychol</source> <volume>7</volume>: <fpage>383</fpage>-<lpage>409</lpage>. doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1146/annurev-clinpsy-032210-104518" xlink:type="simple">10.1146/annurev-clinpsy-032210-104518</ext-link>. PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/21219196" xlink:type="simple">21219196</ext-link>.</mixed-citation>
			</ref>
		</ref-list>
	</back>
</article>